Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1855819

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1855819

Cellular Therapy Tracking Global Market Report 2025

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Cellular therapy tracking refers to the organized process of overseeing and managing the full lifecycle of cellular therapies, including cell collection, production, distribution, administration, and long-term patient monitoring. It maintains product quality, regulatory adherence, patient safety, and treatment success through comprehensive data recording and traceability. It also supports workflow optimization and ensures precise documentation throughout the therapy process.

The primary product categories in cellular therapy tracking are software and services. The software delivers digital platforms and tools to handle, observe, and organize information related to cell therapy activities and procedures. It is applied in areas such as cancer, cardiovascular conditions, musculoskeletal disorders, and more, serving end users including hospitals, research institutions, biotechnology companies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The cellular therapy tracking market research report is one of a series of new reports from The Business Research Company that provides cellular therapy tracking market statistics, including the cellular therapy tracking industry global market size, regional shares, competitors with the cellular therapy tracking market share, detailed cellular therapy tracking market segments, market trends, and opportunities, and any further data you may need to thrive in the cellular therapy tracking industry. This cellular therapy tracking market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cellular therapy tracking market size has grown rapidly in recent years. It will grow from $2.56 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be linked to an increase in clinical trials for regenerative medicine, heightened emphasis on personalized medicine, expansion of collaborations between academia and industry, greater awareness of cell therapy effectiveness and safety, and rising investments and venture capital in cell and gene therapy companies.

The cellular therapy tracking market size is expected to see rapid growth in the next few years. It will grow to $4.71 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be linked to wider adoption of personalized and precision medicine, a growing pipeline of cell and gene therapies, an increase in clinical trials and regulatory approvals, higher incidence of chronic and rare diseases, and expansion of cell therapy manufacturing capabilities. Key trends during the forecast period include integration of cell therapy tracking with digital health platforms, use of bioinformatics in cellular research, advancements in cellular therapy studies, enhanced regulatory-compliance tools, and implementation of AI and machine learning.

The growth of the cellular therapy tracking market is being driven by the increasing use of personalized medicine, particularly due to the growing demand for patient-specific cell monitoring and adherence to regulatory standards. Personalized medicine is an approach that customizes treatment and prevention based on an individual's genetic profile, lifestyle, and environment. This shift is largely fueled by advancements in genomics, which allow for the precise identification of genetic variations and the creation of tailored treatments. Cellular therapy tracking plays a vital role in supporting personalized medicine by ensuring accurate monitoring and management of patient-specific cells throughout therapy. It enhances both the safety and effectiveness of treatments by offering traceability, regulatory compliance, and an efficient workflow for healthcare providers. For example, in February 2024, the Personalized Medicine Coalition (PMC) reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, compared to 12 in 2022. This increase in personalized medicine adoption is propelling the growth of the cellular therapy tracking market.

Key players in the cellular therapy tracking market are focusing on creating scalable platforms, such as chain of identity (COI) management systems, to ensure traceability, regulatory compliance, and patient safety. These COI management platforms are digital systems that track and verify the identity of patient-specific cells throughout the entire therapy process. For example, in May 2023, TrakCel Limited, a UK-based software company, launched OCELLOS Core, part of its OCELLOS suite, designed as a COI management platform for early-stage autologous and personalized cell and gene therapy (CGT) clinical trials. This platform offers automated COI tracking, ensuring accurate patient records from the initial enrollment. The system is pre-configured and validated, allowing deployment within two to three weeks and offering cost-effective scalability as therapies progress from clinical trials to commercialization. It also tracks chain of custody events with full audit trails, improving compliance and collaboration.

In June 2025, STEMCELL Technologies Inc., a biotechnology company based in Canada, acquired Cellular Highways Ltd. for an undisclosed amount. This acquisition allows STEMCELL Technologies to integrate Cellular Highways' advanced cell sorting technology into its offerings, enhancing the precision, scalability, and efficiency of cellular therapy manufacturing and tracking. Cellular Highways Ltd., a UK-based biotechnology firm, specializes in innovative cell sorting technologies for cellular therapy tracking.

Major players in the cellular therapy tracking market are Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Gilead Sciences Inc., Merck KGaA, GE Healthcare Technologies Inc., Becton Dickinson and Company, Lonza Group Ltd., Nikon Corporation, Charles River Laboratories International Inc., Sartorius AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Vericel Corporation, Adaptimmune Therapeutics plc, Medipost Co. Ltd., and TrakCel.

North America was the largest region in the cellular therapy tracking market in 2024. The regions covered in cellular therapy tracking report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cellular therapy tracking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cellular therapy tracking market includes revenues earned by entities through logistics management, temperature-controlled shipping, chain of custody compliance, consulting and advisory support, cryopreservation, secure biostorage, end-to-end supply chain solutions, and quality assurance support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cellular Therapy Tracking Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cellular therapy tracking market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cellular therapy tracking ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cellular therapy tracking market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Software; Services
  • 2) By Application: Cancer; Cardiovascular Diseases; Musculoskeletal Disorders; Autoimmune Diseases; Other Applications
  • 3) By End-User: Hospitals; Research Institutes; Biotechnology Companies; Other End Users
  • Subsegments:
  • 1) By Software: Patient Registry Software; Clinical Trial Management Software; Electronic Data Capture (EDC) Systems; Laboratory Information Management Systems (LIMS); Cell Therapy Supply Chain Management Software; Compliance And Reporting Software; Data Analytics And Visualization Tools
  • 2) By Services: Implementation And Integration Services; Training And Education Services; Consulting Services; Managed Services; Technical Support And Maintenance; Data Security And Compliance Services
  • Companies Mentioned: Johnson & Johnson; Novartis AG; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; Gilead Sciences Inc.; Merck KGaA; GE Healthcare Technologies Inc.; Becton Dickinson and Company; Lonza Group Ltd.; Nikon Corporation; Charles River Laboratories International Inc.; Sartorius AG; Bio-Rad Laboratories Inc.; Bio-Techne Corporation; Miltenyi Biotec B.V. & Co. KG; Promega Corporation; Vericel Corporation; Adaptimmune Therapeutics plc; Medipost Co. Ltd.; TrakCel
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.
Product Code: r38468

Table of Contents

1. Executive Summary

2. Cellular Therapy Tracking Market Characteristics

3. Cellular Therapy Tracking Market Trends And Strategies

4. Cellular Therapy Tracking Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cellular Therapy Tracking Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cellular Therapy Tracking PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cellular Therapy Tracking Market Growth Rate Analysis
  • 5.4. Global Cellular Therapy Tracking Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cellular Therapy Tracking Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cellular Therapy Tracking Total Addressable Market (TAM)

6. Cellular Therapy Tracking Market Segmentation

  • 6.1. Global Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Services
  • 6.2. Global Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Cardiovascular Diseases
  • Musculoskeletal Disorders
  • Autoimmune Diseases
  • Other Applications
  • 6.3. Global Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Research Institutes
  • Biotechnology Companies
  • Other End Users
  • 6.4. Global Cellular Therapy Tracking Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patient Registry Software
  • Clinical Trial Management Software
  • Electronic Data Capture (EDC) Systems
  • Laboratory Information Management Systems (LIMS)
  • Cell Therapy Supply Chain Management Software
  • Compliance And Reporting Software
  • Data Analytics And Visualization Tools
  • 6.5. Global Cellular Therapy Tracking Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implementation And Integration Services
  • Training And Education Services
  • Consulting Services
  • Managed Services
  • Technical Support And Maintenance
  • Data Security And Compliance Services

7. Cellular Therapy Tracking Market Regional And Country Analysis

  • 7.1. Global Cellular Therapy Tracking Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cellular Therapy Tracking Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cellular Therapy Tracking Market

  • 8.1. Asia-Pacific Cellular Therapy Tracking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cellular Therapy Tracking Market

  • 9.1. China Cellular Therapy Tracking Market Overview
  • 9.2. China Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cellular Therapy Tracking Market

  • 10.1. India Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cellular Therapy Tracking Market

  • 11.1. Japan Cellular Therapy Tracking Market Overview
  • 11.2. Japan Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cellular Therapy Tracking Market

  • 12.1. Australia Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cellular Therapy Tracking Market

  • 13.1. Indonesia Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cellular Therapy Tracking Market

  • 14.1. South Korea Cellular Therapy Tracking Market Overview
  • 14.2. South Korea Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cellular Therapy Tracking Market

  • 15.1. Western Europe Cellular Therapy Tracking Market Overview
  • 15.2. Western Europe Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cellular Therapy Tracking Market

  • 16.1. UK Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cellular Therapy Tracking Market

  • 17.1. Germany Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cellular Therapy Tracking Market

  • 18.1. France Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cellular Therapy Tracking Market

  • 19.1. Italy Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cellular Therapy Tracking Market

  • 20.1. Spain Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cellular Therapy Tracking Market

  • 21.1. Eastern Europe Cellular Therapy Tracking Market Overview
  • 21.2. Eastern Europe Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cellular Therapy Tracking Market

  • 22.1. Russia Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cellular Therapy Tracking Market

  • 23.1. North America Cellular Therapy Tracking Market Overview
  • 23.2. North America Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cellular Therapy Tracking Market

  • 24.1. USA Cellular Therapy Tracking Market Overview
  • 24.2. USA Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cellular Therapy Tracking Market

  • 25.1. Canada Cellular Therapy Tracking Market Overview
  • 25.2. Canada Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cellular Therapy Tracking Market

  • 26.1. South America Cellular Therapy Tracking Market Overview
  • 26.2. South America Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cellular Therapy Tracking Market

  • 27.1. Brazil Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cellular Therapy Tracking Market

  • 28.1. Middle East Cellular Therapy Tracking Market Overview
  • 28.2. Middle East Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cellular Therapy Tracking Market

  • 29.1. Africa Cellular Therapy Tracking Market Overview
  • 29.2. Africa Cellular Therapy Tracking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cellular Therapy Tracking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cellular Therapy Tracking Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cellular Therapy Tracking Market Competitive Landscape And Company Profiles

  • 30.1. Cellular Therapy Tracking Market Competitive Landscape
  • 30.2. Cellular Therapy Tracking Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cellular Therapy Tracking Market Other Major And Innovative Companies

  • 31.1. Merck KGaA
  • 31.2. GE Healthcare Technologies Inc.
  • 31.3. Becton Dickinson and Company
  • 31.4. Lonza Group Ltd.
  • 31.5. Nikon Corporation
  • 31.6. Charles River Laboratories International Inc.
  • 31.7. Sartorius AG
  • 31.8. Bio-Rad Laboratories Inc.
  • 31.9. Bio-Techne Corporation
  • 31.10. Miltenyi Biotec B.V. & Co. KG
  • 31.11. Promega Corporation
  • 31.12. Vericel Corporation
  • 31.13. Adaptimmune Therapeutics plc
  • 31.14. Medipost Co. Ltd.

32. Global Cellular Therapy Tracking Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cellular Therapy Tracking Market

34. Recent Developments In The Cellular Therapy Tracking Market

35. Cellular Therapy Tracking Market High Potential Countries, Segments and Strategies

  • 35.1 Cellular Therapy Tracking Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cellular Therapy Tracking Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cellular Therapy Tracking Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!